Cite
Gabapentin Enacarbil Extended‐Release for Alcohol Use Disorder: A Randomized, Double‐Blind, Placebo‐Controlled, Multisite Trial Assessing Efficacy and Safety.
MLA
Falk, Daniel E., et al. “Gabapentin Enacarbil Extended‐Release for Alcohol Use Disorder: A Randomized, Double‐Blind, Placebo‐Controlled, Multisite Trial Assessing Efficacy and Safety.” Alcoholism: Clinical & Experimental Research, vol. 43, no. 1, Jan. 2019, pp. 158–69. EBSCOhost, https://doi.org/10.1111/acer.13917.
APA
Falk, D. E., Ryan, M. L., Fertig, J. B., Devine, E. G., Cruz, R., Brown, E. S., Burns, H., Salloum, I. M., Newport, D. J., Mendelson, J., Galloway, G., Kampman, K., Brooks, C., Green, A. I., Brunette, M. F., Rosenthal, R. N., Dunn, K. E., Strain, E. C., Ray, L., & Shoptaw, S. (2019). Gabapentin Enacarbil Extended‐Release for Alcohol Use Disorder: A Randomized, Double‐Blind, Placebo‐Controlled, Multisite Trial Assessing Efficacy and Safety. Alcoholism: Clinical & Experimental Research, 43(1), 158–169. https://doi.org/10.1111/acer.13917
Chicago
Falk, Daniel E., Megan L. Ryan, Joanne B. Fertig, Eric G. Devine, Ricardo Cruz, E. Sherwood Brown, Heather Burns, et al. 2019. “Gabapentin Enacarbil Extended‐Release for Alcohol Use Disorder: A Randomized, Double‐Blind, Placebo‐Controlled, Multisite Trial Assessing Efficacy and Safety.” Alcoholism: Clinical & Experimental Research 43 (1): 158–69. doi:10.1111/acer.13917.